Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Indications for testing among reported cases of HCV infection from enhanced hepatitis surveillance sites in the United States, 2004-2010.

Mahajan R, Liu SJ, Klevens RM, Holmberg SD.

Am J Public Health. 2013 Aug;103(8):1445-9. doi: 10.2105/AJPH.2013.301211. Epub 2013 Jun 13.

2.

Vital signs: evaluation of hepatitis C virus infection testing and reporting - eight U.S. sites, 2005-2011.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2013 May 10;62(18):357-61.

3.

Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department.

Hsieh YH, Rothman RE, Laeyendecker OB, Kelen GD, Avornu A, Patel EU, Kim J, Irvin R, Thomas DL, Quinn TC.

Clin Infect Dis. 2016 May 1;62(9):1059-65. doi: 10.1093/cid/ciw074. Epub 2016 Feb 21.

4.

Evaluation of the Impact of Mandating Health Care Providers to Offer Hepatitis C Virus Screening to All Persons Born During 1945-1965 - New York, 2014.

Flanigan CA, Leung SJ, Rowe KA, Levey WK, King A, Sommer JN, Morne JE, Zucker HA.

MMWR Morb Mortal Wkly Rep. 2017 Sep 29;66(38):1023-1026. doi: 10.15585/mmwr.mm6638a3.

5.

Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.

Smith BD, Teshale E, Jewett A, Weinbaum CM, Neaigus A, Hagan H, Jenness SM, Melville SK, Burt R, Thiede H, Al-Tayyib A, Pannala PR, Miles IW, Oster AM, Smith A, Finlayson T, Bowles KE, Dinenno EA.

Clin Infect Dis. 2011 Oct;53(8):780-6. doi: 10.1093/cid/cir499.

PMID:
21921221
6.
7.

Seroprevalence of HCV and HIV infections by year of birth in Spain: impact of US CDC and USPSTF recommendations for HCV and HIV testing.

Mena A, Moldes L, Meijide H, Cañizares A, Castro-Iglesias A, Delgado M, Pértega S, Pedreira J, Bou G, Poveda E.

PLoS One. 2014 Dec 1;9(12):e113062. doi: 10.1371/journal.pone.0113062. eCollection 2014.

8.

Surveillance for acute viral hepatitis - United States, 2007.

Daniels D, Grytdal S, Wasley A; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2009 May 22;58(3):1-27.

9.

A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study.

Southern WN, Norton B, Steinman M, DeLuca J, Drainoni ML, Smith BD, Litwin AH.

BMC Infect Dis. 2015 Dec 1;15:553. doi: 10.1186/s12879-015-1283-3.

10.

CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.

Johnson NB, Hayes LD, Brown K, Hoo EC, Ethier KA; Centers for Disease Control and Prevention (CDC).

MMWR Suppl. 2014 Oct 31;63(4):3-27.

PMID:
25356673
11.

Birth cohort testing for hepatitis C virus: implications for clinical social workers in health care settings.

Sims OT, Whalen CC, Nackerud LG, Bride BE.

Soc Work Health Care. 2013;52(8):689-703. doi: 10.1080/00981389.2013.806385.

PMID:
24028735
12.

Knowledge about Hepatitis C Virus Infection and Acceptability of Testing in the 1945-1965 Birth Cohort (Baby Boomers) Presenting to a Large Urban Emergency Department: A Pilot Study.

Allison WE, Chiang W, Rubin A, Oshva L, Carmody E.

J Emerg Med. 2016 Jun;50(6):825-831.e2. doi: 10.1016/j.jemermed.2016.02.001. Epub 2016 Mar 4.

PMID:
26954104
13.

HIV and hepatitis C virus infection in the United States: whom and how to test.

Panneer N, Lontok E, Branson BM, Teo CG, Dan C, Parker M, Stekler JD, DeMaria A Jr, Miller V.

Clin Infect Dis. 2014 Sep 15;59(6):875-82. doi: 10.1093/cid/ciu396. Epub 2014 May 27. Review.

PMID:
24867787
14.

Underascertainment of acute hepatitis C virus infections in the U.S. surveillance system: a case series and chart review.

Onofrey S, Aneja J, Haney GA, Nagami EH, DeMaria A Jr, Lauer GM, Hills-Evans K, Barton K, Kulaga S, Bowen MJ, Cocoros N, McGovern BH, Church DR, Kim AY.

Ann Intern Med. 2015 Aug 18;163(4):254-61. doi: 10.7326/M14-2939.

15.
16.

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ.

Ann Intern Med. 2006 May 16;144(10):705-14.

PMID:
16702586
17.

Hepatitis C screening beyond CDC guidelines in an Egyptian immigrant community.

Perumalswami PV, DeWolfe Miller F, Orabee H, Regab A, Adams M, Kapelusznik L, Aljibawi F, Pagano W, Tong V, Dieterich DT.

Liver Int. 2014 Feb;34(2):253-8. doi: 10.1111/liv.12259. Epub 2013 Jul 25.

PMID:
23890188
18.

Electronic matching of HIV/AIDS and hepatitis C surveillance registries in three states.

Speers S, Klevens RM, Vonderwahl C, Bryant T, Daniloff E, Capizzi J, Poissant T, Roome A.

Public Health Rep. 2011 May-Jun;126(3):344-8.

19.

Community-based HCV screening: knowledge and attitudes in a high risk urban population.

Norton BL, Voils CI, Timberlake SH, Hecker EJ, Goswami ND, Huffman KM, Landgraf A, Naggie S, Stout JE.

BMC Infect Dis. 2014 Feb 10;14:74. doi: 10.1186/1471-2334-14-74.

20.

Hepatitis C virus testing perspectives among primary care physicians in four large primary care settings.

Jewett A, Garg A, Meyer K, Wagner LD, Krauskopf K, Brown KA, Pan JJ, Massoud O, Smith BD, Rein DB.

Health Promot Pract. 2015 Mar;16(2):256-63. doi: 10.1177/1524839914532291. Epub 2014 Apr 28.

Supplemental Content

Support Center